Recombinant Influenza A H1N1 (Solomon Islands) Antigen

Specification

• Cat#: VAC-0009
• Product Name: Recombinant Influenza A H1N1 (Solomon Islands) Antigen
• Description: Recombinant Full-Length H1N1 A/Solomon Islands/03/2006 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells.
• Species: Influenza A virus
• Source: Baculovirus Insect Cells.
• Introduction: H1N1 is a subtype specie of Influenza A virus. H1N1 Influenza Virus has mutated into various strains such as the Spanish Flu strain, mild human flu strains, endemic pigstrains, and various strains found in birds. The Influenza A Virus is a globular particle about 100nm in diameter, sheathed in a lipid bilayer derived from the plasma membrane of its host. Studded in the lipid bilayer are two integral membrane proteins some 500 molecules of hemagglutinin (\"H\") and some 100 molecules of neuraminidase (\"N\"). Within the lipid bilayer are 3000 molecules of matrix protein and 8 pieces of RNA. Each of the 8 RNA molecules is associated with many copies of a nucleoprotein, several molecules of the three subunits of its RNA polymerase some \"non-structural\" protein molecules of uncertain function.
• Purity: Greater than 90.0% as determined by SDS-PAGE.
• Stability: H1N1 A/Solomon Islands/03/2006 Recombinant should be stored at 4°C.
• Usage: All the products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.